AZNH Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 -2.85%, SMA50 -2.75%, SMA200 11.4%). The stock’s 14-day RSI is 42.32 (neutral), while the ATR of 0.8 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -6.36% below its high and over 37.53% above its low.

Our AI price prediction model suggests that AstraZeneca PLC ADRHedged ETF stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

AstraZeneca PLC ADRhedged last paid a dividend of 0.58 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

currently trading near 52-week highs band.

AstraZeneca PLC ADRhedged (AMEX:AZNH) closed at $53.74 USD, gaining $0.01 (0.03%) from the previous close of $53.73. The stock is currently mid-range between its 52-week high and low $38.74 and $56.90. With a market capitalization of about $1.60 million, AstraZeneca PLC ADRhedged is classified as a micro-cap and shows lower-than-market volatility (beta ~0.30). Key stats such as the average daily volume over the past year has been around 4.38 thousand shares, trading with heavier-than-usual volume. Headquartered in Cambridge, None, AstraZeneca PLC ADRhedged operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Under typical circumstances, this Series primarily dedicates a minimum of 95% of its net assets to American Depositary Receipts (ADRs) that represent shares of AstraZeneca PLC. It's crucial to understand that the Series will not directly acquire stock in AstraZeneca PLC. ADRs are essentially certificates issued by an American financial institution (a bank or trust company) that confirm ownership of underlying securities from a company based outside the U.S.